Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

Clinical trial NCT01639911 · COMPLETED

Trial details

NCT number: NCT01639911
Sponsor: University of Illinois at Chicago
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm of Breast CNS Malignancy Malignant Neoplasm of Gastrointestinal Tract Genitourinary Neoplasms Malignancy and Gender Unspecified Head and Neck Neoplasms Melanoma Malignant Neoplasm of Thorax

Start date: 2013-08-14
Primary completion: 2016-07-28
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.